# AI Governance + Interoperability Readiness Pilot

## Proposed Engagement
- Status: sellable-now
- Duration: 45-60 days
- Recommended commercial model: Recommended readiness range: $75k-$225k based on organizations, workflows, standards scope, and review depth
- Target buyer: CIO, compliance, security, clinical governance, and integration leadership teams
- Request route: /pilot?offer=ai-readiness-governance-audit

## Objective
Create an actionable AI asset, governance, interoperability, and production-readiness register before healthcare AI deployment.

## Deliverables
- AI Asset Registry and shadow-AI findings
- Governance and approval gap report
- Standards, connector, and conformance target map
- Trust, audit, identity, and runtime safety decision register
- Executive remediation roadmap

## Included Product Proof
- [Atlas Interoperability Readiness Demo](/demos/atlas-interoperability-readiness): Demonstrate standards-aware synthetic conformance evidence with exact live-use blockers retained.
- [AgentOS Governance Evaluation Demo](/demos/agentos-governance-evaluation): Demonstrate how a synthetic enterprise workflow packet becomes a governed multi-agent plan and Atlas Trust Card.

## Decision Metrics
- AI assets and owners inventoried
- High-risk governance gaps assigned
- Interoperability targets and blockers approved
- Deployment decision path made explicit

## Buyer Inputs
- AI, integration, workflow, and vendor inventory
- Security and compliance policies
- Target standards and trading partners
- Executive risk and deployment priorities

## Governance Gates
- Assessment access follows least privilege
- No patient records required
- Findings require accountable owner and disposition
- Production authorization remains outside the assessment

## Production Exclusions
- No certification claim
- No live connector implementation
- No production AI authorization
- No clinical advice

## Product Boundary
SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

This non-binding proposal is a starting point for enterprise scoping. Final scope, pricing, security requirements, legal terms, success criteria, and production permissions require written buyer and SCRIMED approval.